JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 13, 2003; DOI: 10.1124/jpet.103.056242


0022-3565/03/3073-1135-1141$20.00
JPET 307:1135-1141, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.056242v1
307/3/1135    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, H.-E.
Right arrow Articles by Tseng, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, H.-E.
Right arrow Articles by Tseng, L. F.

NEUROPHARMACOLOGY

Dynorphinergic Mechanism Mediating Endomorphin-2-Induced Antianalgesia in the Mouse Spinal Cord

Hsiang-En Wu, Han-Sen Sun, Moses Darpolar, Randy J. Leitermann, John P. Kampine, and Leon F. Tseng

Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin

We have previously demonstrated that both endomorphin-1 (EM-1) and endomorphin-2 (EM-2) at high doses (1.75–35 nmol) given intrathecally (i.t.) or intracerebroventricularly produce antinociception by stimulation of µ-opioid receptors. Now, we report that EM-2 at small doses (0.05–1.75 nmol), which injected alone did not produce antinociception, produces anti-analgesia against opioid agonist-induced antinociception. The tail-flick (TF) response was used to test the antinociception in male CD-1 mice. Intrathecal pretreatment with EM-2 (0.02–1.75 nmol) 45 min before i.t. morphine (3.0 nmol) injection dose dependently attenuated morphine-induced TF inhibition. On the other hand, a similar dose of EM-1 (1.64 nmol) failed to produce any antianalgesic effect. The EM-2 (1.75 nmol)-produced anti-analgesia against morphine-induced TF inhibition was blocked by i.t. pretreatment with the µ-opioid antagonist naloxone or 3-methoxynaltrexone, but not {delta}-opioid receptor antagonist naltrindole, {kappa}-opioid receptor antagonist nor-binaltorphimine, or N-methyl-D-aspartate (NMDA) receptor antagonist MK-801. The EM-2-induced antianalgesic effect against morphine-induced TF inhibition was blocked by i.t. pretreatment with antiserum against dynorphin A(1-17), but not {beta}-endorphin, [Met]-enkephalin, [Leu]-enkephalin, or cholecystokinin antiserum (200 µg each). The i.t. EM-2 pretreatment also attenuated the TF inhibition induced by other µ-opioid agonists, [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin, EM-1 and EM-2, {delta}-opioid agonist deltorphin II, and {kappa}-opioid agonist (trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide methane-sulfonate hydrate (U50,488H). It is concluded that EM-2 at subanalgesic doses presumably stimulates a subtype of µ-opioid receptor and subsequently induces the release of dynorphin A(1-17) to produce antianalgesic effects against µ-, {delta}-, or {kappa}-agonists-induced antinociception. The EM-2-induced antianalgesia is not mediated by the release of [Met]-enkephalin, [Leu]-enkephalin, {beta}-endorphin, or cholecystokinin, nor does it involve {kappa}- or {delta}-opioid or NMDA receptors in the spinal cord.


Received June 27, 2003; accepted September 5, 2003.

Address correspondence to: Dr. Leon F. Tseng, Department of Anesthesiology, Medical College of Wisconsin Medical Education Building, Room M4308, 8701 Watertown Plank Rd., Milwaukee, WI 53226. E-mail: ltseng{at}post.its.mcw.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H.-E. Wu, J. Thompson, H.-S. Sun, M. Terashvili, and L. F. Tseng
Antianalgesia: Stereoselective Action of dextro-Morphine over levo-Morphine on Glia in the Mouse Spinal Cord
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1101 - 1108.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Terashvili, H.-e. Wu, R. J. Leitermann, H.-S. Sun, A. D. Clithero, and L. F. Tseng
Differential Mechanisms of Antianalgesia Induced by Endomorphin-1 and Endomorphin-2 in the Ventral Periaqueductal Gray of the Rat
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-E. Wu, J. Thompson, H.-S. Sun, R. J. Leitermann, J. M. Fujimoto, and L. F. Tseng
Nonopioidergic Mechanism Mediating Morphine-Induced Antianalgesia in the Mouse Spinal Cord
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 240 - 246.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.